THERAPY OF PANCREATIC CARCINOMAS (PACA) TRANSPLANTATION TUMORS WITH ANTI-CA19-9-I-131 AS WELL AS ANTI-CA19-9+ANTI-CEA-I-131

被引：0
|
作者：
KLAPDOR, R [1 ]
LANDER, S [1 ]
BAHLO, M [1 ]
MONTZ, R [1 ]
机构：
[1] UNIV HAMBURG,MED KERNKLIN & POLIKLIN,NUKL MED ABT,D-2000 HAMBURG 13,FED REP GER
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 1986年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：533 / 533
页数：1
相关论文
共 50 条
  • [41] A PRECLINICAL COMPARISON OF THERAPY AND TOXICITY FOR MU-9 ANTI-CSAP IGG LABELED WITH I-131, Y-90 OR RE-188
    BLUMENTHAL, RD
    SHARKEY, RM
    FORMAN, D
    RODRIGUEZ, B
    GOLDENBERG, DM
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P215 - P215
  • [42] 111-IN LABELED ANTI CA-19-9 ANTIBODIES IMMUNOSCINTIGRAPHY IN COLORECTAL-CARCINOMA-1ST RESULTS
    KOSTIC, K
    OBRADOVIC, V
    UGLJESIC, M
    ADANJAGRUJIC, G
    ARTIKO, V
    DAVIDOVIC, B
    PERIODICUM BIOLOGORUM, 1991, 93 (03) : 435 - 436
  • [43] CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer
    Suehiro, Yutaka
    Suenaga, Shigeyuki
    Kunimune, Yuki
    Yada, Shoko
    Hamamoto, Kaori
    Tsuyama, Takanori
    Amano, Shogo
    Matsui, Hiroto
    Higaki, Shingo
    Fujii, Ikuei
    Suzuki, Chieko
    Hoshida, Tomomi
    Matsumoto, Toshihiko
    Fujimoto, Yuko
    Kaino, Seiji
    Shinjo, Keiko
    Kondo, Yutaka
    Sakaida, Isao
    Takami, Taro
    Nagano, Hiroaki
    Yamasaki, Takahiro
    ONCOLOGY, 2022, : 674 - 684
  • [44] INCREASED CA125 ELEVATION IN PATIENTS AFTER ADMINISTRATION OF I-131-OC125 CAUSED BY HUMAN ANTI-MOUSE ANTIBODIES
    HAISMA, HJ
    MOSELEY, KR
    KNAPP, RC
    BOVEN, E
    PINEDO, HM
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 316 - 317
  • [45] Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody
    Gautherot, E
    Kraeber-Bodéré, F
    Daniel, L
    Fiche, M
    Rouvier, E
    Saï-Maurel, C
    Thedrez, P
    Chatal, JF
    Barbet, J
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3177S - 3182S
  • [46] Carcinoembryonic antigen (CEA) and the carcinoma antigen 19-9 (CA 19-9) together in early diagnosis of Stage I-II colorectal adenocarcinoma. A case-control study
    Lumachi, F.
    Chiara, G.
    Tozzoli, R.
    Lo Re, G.
    Basso, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 7 - 8
  • [47] The Relationship between Nutritional Status and Body Composition with Clinical Parameters, Tumor Stage, CA19-9, CEA Levels in Patients with Pancreatic and Periampullary Tumors
    Jachnis, Aneta
    Slodkowski, Maciej Tomasz
    CURRENT ONCOLOGY, 2021, 28 (06) : 4805 - 4820
  • [48] An engineered anti-CA19-9 cys-diabody for PET imaging of pancreas cancer and targeting of polymerized liposomal nanoparticles
    Girgis, M. D.
    McCabe, K.
    Olafsen, T.
    Bergara, F.
    Kenanova, V.
    Federman, N.
    Wu, A.
    Tomlinson, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [49] Serum CA19-9 in combination with methylated HOXA1 and SST is useful to diagnose stage I pancreatic cancer
    Suehiro, Yutaka
    Shinjo, Keiko
    Kondo, Yutaka
    Takami, Taro
    Yamasaki, Takahiro
    CANCER SCIENCE, 2024, 115 : 1580 - 1580
  • [50] POTENTIAL CONTRIBUTION OF I-131-LABELED MONOCLONAL ANTI-CEA ANTIBODIES IN THE TREATMENT OF LIVER METASTASES FROM COLORECTAL CARCINOMAS - PRETHERAPEUTIC STUDY WITH DOSE RECOVERY IN RESECTED TISSUES
    YCHOU, M
    RICARD, M
    LUMBROSO, J
    ROUGIER, P
    MACH, JP
    BUCHEGGER, F
    SACCAVINI, JC
    LASSER, P
    ELIAS, D
    ESCHWEGE, F
    PARMENTIER, C
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (08) : 1105 - 1111
12345